Qube Research & Technologies (QRT)
LENZ

Qube Research & Technologies (QRT)’s LENZ Therapeutics LENZ Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,290
Closed -$709K – 4237
2025
Q4 		$709K Buy
+44,290
New +$1.29M ﹤0.01% 2695
2024
Q2 		– Sell
-982
Closed -$21.9K – 4872
2024
Q1 		$21.9K Buy
+982
New +$20.4K ﹤0.01% 3676
2023
Q1 		– Sell
-3,872
Closed -$90K – 3116
2022
Q4 		$90K Buy
3,872
+1,016
+36% +$23.6K ﹤0.01% 2029
2022
Q3 		$63K Buy
2,856
+336
+13% +$8.01K ﹤0.01% 2090
2022
Q2 		$49K Buy
+2,520
New +$56.2K ﹤0.01% 2133
2021
Q3 		– Sell
-2,100
Closed -$452K – 2869
2021
Q2 		$452K Buy
+2,100
New +$366K 0.01% 1337

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LENZ Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of LENZ Therapeutics (LENZ) in Q1 2026, closing a stake of 44,290 shares — an estimated $709K sold.

Qube Research & Technologies (QRT) first reported a position in LENZ in Q2 2021 and held it in 6 quarters. The position peaked at $709K in Q4 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining LENZ Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 44,290 LENZ Therapeutics shares in Q1 2026, an estimated $709K.
  • Qube Research & Technologies (QRT) first reported a position in LENZ Therapeutics in Q2 2021 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s LENZ Therapeutics position peaked at $709K in Q4 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.